• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Gastro 40
    / Unipharm


    Active Ingredient
    Famotidine 40 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    20 X 40 mg

    full basket chart 8009 7208

    Tablets

    30 X 40 mg

    full basket chart 40128

    Related information


    Dosage

    This medicine is not usually intended for administration to children and infants.
    Directions for use: Do not chew! Swallow the medicine with a small amount of water. It is advisable to take the medicine with a meal and the last daily dose before bedtime.
    See prescribing information for full details.


    Indications

    H2 – receptor antagonist for reduction of gastric secretion and acid in duodenal ulcer, prevention of relapse of duodenal ulcer, benign gastric ulcer, Zolinger-Ellison syndrome.


    Contra-Indications

    Known hypersensitivity.


    Special Precautions

    Symptomatic response to famotidine does not preclude gastric malignancy. Pregnancy and lactation, pediatrics, severe renal impairment, cirrhosis or impaired hepatic function.


    Side Effects

    Headache, dizziness, constipation, diarrhea, dry mouth, nausea and/or vomiting, rash, abdominal discomfort or distension, anorexia, fatigue, loss of hair and ringing in ears.


    Drug interactions

    Coumarin anticoagulants, carbamazepine, diltiazem, propranolol, quinidine, quinine, labetalol, lignocaine, nifedipine, felodipine, pethidine, triamterene, amiodarone, procainamide, metformin, flecainide, tricyclic antidepressants, xanthines, phenytoin, chlormethiazole, metronidazole, alprazolam, chlordiazepoxide, diazepam, midazolan, nitrazepam, propafenone, piroxicam, terbinafine. Ketoconazole, rifampicin, sucralfate, octreotide.


    Manufacturer
    Trima Israel Pharmaceutical Products Maabarot Ltd. Israel
    CLOSE